Jeremy Bender, CHIEF EXECUTIVE OFFICER at Day One Biopharmaceuticals, Inc. (DAWN), sold 158,416 shares at $17.88 ($2.8M) on 2024-05-01, disclosed to the SEC on 2024-05-03.
Scheduled sale ($2.8M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.88 | 70,051 | $1.3M | 44.2% |
| 2 | $17.88 | 70,051 | $1.3M | 44.2% |
| 3 | $17.94 | 6 | $108 | 0.0% |
| 4 | $17.85 | 9,154 | $163K | 5.8% |
| 5 | $17.85 | 9,154 | $163K | 5.8% |
| Total | $17.88 avg | 158,416 |
| $2.8M |
| 100% |
| Filing → |
| DAWN | SELL | 2025-08-19 | $217K | — | Filing → |
| DAWN | SELL | 2025-05-19 | $175K | — | Filing → |
| DAWN | SELL | 2025-02-21 | $288K | — | Filing → |